Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Darrington, D L
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1994 - 2527-34 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0732-183X
10.1200/JCO.1994.12.12.2527 doi
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation--adverse effects
Case-Control Studies
Cohort Studies
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Hodgkin Disease--mortality
Humans
Incidence
Leukemia, Myeloid, Acute--epidemiology
Lymphoma, Non-Hodgkin--mortality
Male
Middle Aged
Myelodysplastic Syndromes--epidemiology
Prognosis
Radiotherapy Dosage
Risk Factors
Survival Rate
Whole-Body Irradiation
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 1994 - 2527-34 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0732-183X
10.1200/JCO.1994.12.12.2527 doi
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation--adverse effects
Case-Control Studies
Cohort Studies
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Hodgkin Disease--mortality
Humans
Incidence
Leukemia, Myeloid, Acute--epidemiology
Lymphoma, Non-Hodgkin--mortality
Male
Middle Aged
Myelodysplastic Syndromes--epidemiology
Prognosis
Radiotherapy Dosage
Risk Factors
Survival Rate
Whole-Body Irradiation